NDC 0944-2700-03 Gammagard Liquid
Immune Globulin Infusion (human) Injection, Solution Intravenous; Subcutaneous

Package Information

What is NDC 0944-2700-03?

The NDC Packaged Code 0944-2700-03 is assigned to a package of 1 bottle, glass in 1 carton / 25 ml in 1 bottle, glass (0944-2700-09) of Gammagard Liquid, a plasma derivative labeled by Baxalta Us Inc.. The product's dosage form is injection, solution and is administered via intravenous; subcutaneous form. The following table has all the important details about this NDC code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

Field Name Field Value
NDC Package Code 0944-2700-03
Package Description 1 BOTTLE, GLASS in 1 CARTON / 25 mL in 1 BOTTLE, GLASS (0944-2700-09)
Product Code 0944-2700
Proprietary Name What is the Proprietary Name?
The proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.		 Gammagard Liquid
Non-Proprietary Name What is the Non-Proprietary Name?
The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.		 Immune Globulin Infusion (human)
Substance Name What is the Substance Name?
An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.		 Human Immunoglobulin G
Usage Information Product Usage Information
The drug use information is a summary and does NOT have all possible information about this product. This information does not assure that this product is safe, effective, or appropriate. This information is not individual medical advice and does not substitute for the advice of a health care professional. Always ask a health care professional for complete information about this product and your specific health needs.		 This medication is used in people with a certain type of weakened immune system (primary immune deficiency) to strengthen it and to lower the risk of infection. This medication is made from human blood that has a high level of antibodies which help fight infections. This product is also used to increase the number of certain blood cells (platelets) in people with a certain blood disorder (idiopathic thrombocytopenic purpura-ITP). Platelets are needed to stop bleeding and to form normal blood clots. In addition, this medication is used to treat a certain nerve disorder (chronic inflammatory demyelinating polyneuropathy-CIDP). This disorder causes weakness and numbness/tingling/pain in the arms and legs. This medication helps to improve these symptoms and prevents relapse.
11-Digit NDC Billing Format NDC Format for Billing
For insurance billing purposes the Centers for Medicare & Medicaid Services (CMS) created an 11 digit NDC derivative identifier. If the NDC Package code is less than 11 digits the code must be padded with leading zeros. The leading zeros must be added to the appropriate segment to create a 5-4-2 configuration.		 00944270003
Billing Unit ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
NDC to RxNorm Crosswalk
  • RxCUI: 1809414 - immunoglobulin G, human 10 % in 50 ML Injection
  • RxCUI: 1809414 - 50 ML immunoglobulin G, human 100 MG/ML Injection
  • RxCUI: 1809414 - immunoglobulin G, human 10 % per 50 ML Injection
  • RxCUI: 1809414 - immunoglobulin G, human 5 GM per 50 ML Injection
  • RxCUI: 1809421 - immunoglobulin G, human 10 % in 100 ML Injection
    • Product Type What kind of product is this?
    Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.    		 Plasma Derivative
    Labeler Name Baxalta Us Inc.
    Dosage Form Injection, Solution - A liquid preparation containing one or more drug substances dissolved in a suitable solvent or mixture of mutually miscible solvents that is suitable for injection.
    Administration Route(s)
    • Intravenous - Administration within or into a vein or veins.
    • Subcutaneous - Administration beneath the skin; hypodermic. Synonymous with the term SUBDERMAL.
    Active Ingredient(s)
    Pharmacologic Class(es)
    Sample Package Sample Package?
    This field Indicates whether this package is a sample packaging or not.    		 No
    Marketing Category What is the Marketing Category?
    Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.    		 BLA - A product marketed under an approved Biologic License Application.
    FDA Application Number What is the FDA Application Number?
    This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.    		 BLA125105
    Start Marketing Date What is the Start Marketing Date?
    This is the date that the labeler indicates was the start of its marketing of the drug product.    		 04-27-2005
    Listing Expiration Date What is the Listing Expiration Date?
    This is the date when the listing record will expire if not updated or certified by the product labeler.    		 12-31-2023
    Exclude Flag What is the NDC Exclude Flag?
    This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".     		N
    NDC Code Structure

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    NDC HCPCS Crosswalk

    This crosswalk is intended to help the public understand which drug products (identified by NDCs) are assigned to which HCPCS billing codes.

    NDC 0944-2700-03 HCPCS crosswalk information with package details and bill units information.

    NDC Billing CodeHCPCS CodeHCPCS Code Desc.DosagePackage SizePackage QuantityBillable UnitsBillable Units / Pkg
    00944270003J1569Gammagard liquid injection500 MG25155

    * Please review the disclaimer below.

    Other Product Packages

    The following packages are also available for Gammagard Liquid with product NDC 0944-2700.

    NDC Package CodePackage Description
    0944-2700-021 BOTTLE, GLASS in 1 CARTON / 10 mL in 1 BOTTLE, GLASS (0944-2700-08)
    0944-2700-041 BOTTLE, GLASS in 1 CARTON / 50 mL in 1 BOTTLE, GLASS (0944-2700-10)
    0944-2700-051 BOTTLE, GLASS in 1 CARTON / 100 mL in 1 BOTTLE, GLASS (0944-2700-11)
    0944-2700-061 BOTTLE, GLASS in 1 CARTON / 200 mL in 1 BOTTLE, GLASS (0944-2700-12)
    0944-2700-071 BOTTLE, GLASS in 1 CARTON / 300 mL in 1 BOTTLE, GLASS (0944-2700-13)

    * Please review the disclaimer below.